| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.24 | 3e-07 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-07 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-06 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-06 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-06 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-06 |